These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36923432)

  • 1. Zinc finger and SCAN domain containing 1, ZSCAN1, is a novel stemness-related tumor suppressor and transcriptional repressor in breast cancer targeting TAZ.
    Chu J; Li Y; He M; Zhang H; Yang L; Yang M; Liu J; Cui C; Hong L; Hu X; Zhou L; Li T; Li C; Fan H; Jiang G; Lang T
    Front Oncol; 2023; 13():1041688. PubMed ID: 36923432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1.
    Tian C; Lang T; Qiu J; Han K; Zhou L; Min D; Zhang Z; Qi D
    Cancer Cell Int; 2020 Dec; 20(1):579. PubMed ID: 33292299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.
    Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J
    Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
    Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
    EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis.
    Ding Y; Li Y; Duan Y; Wang W; Zheng W; Cheng W; Qi Y; Feng J; Chen Z; Yu T; Hu A; Wang T; Li M; Zhang H; Li Y; Ma F; Guo B
    J Oncol; 2022; 2022():9999343. PubMed ID: 35518784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
    De Santis F; Romero-Cordoba SL; Castagnoli L; Volpari T; Faraci S; Fucà G; Tagliabue E; De Braud F; Pupa SM; Di Nicola M
    Cell Oncol (Dordr); 2022 Apr; 45(2):257-274. PubMed ID: 35357654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway.
    Dong W; Cao Z; Pang Y; Feng T; Tian H
    Onco Targets Ther; 2019; 12():9041-9051. PubMed ID: 31802911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B.
    Li X; Chen W; Huang L; Zhu M; Zhang H; Si Y; Li H; Luo Q; Yu B
    Pharmacol Res; 2022 May; 179():106222. PubMed ID: 35413424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness.
    Li Y; Wang D; Liu J; Li Y; Chen D; Zhou L; Lang T; Zhou Q
    Onco Targets Ther; 2020; 13():7151-7163. PubMed ID: 32801747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 15. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
    Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
    Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.
    Zhang H; Lang TY; Zou DL; Zhou L; Lou M; Liu JS; Li YZ; Ding DY; Li YC; Zhang N; Zheng XD; Zeng XH; Zhou Q; Li L
    Onco Targets Ther; 2019; 12():11691-11700. PubMed ID: 32021247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
    Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
    Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
    J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.